Dose-modifying factor for captopril for mitigation of radiation injury to normal lung

Our goal is to develop countermeasures for pulmonary injury following unpredictable events such as radiological terrorism or nuclear accidents. We have previously demonstrated that captopril, an angiotensin converting enzyme (ACE) inhibitor, is more effective than losartan, an angiotensin type-1 rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Medhora, Meetha, Gao, Feng, Fish, Brian L., Jacobs, Elizabeth R., Moulder, John E., Szabo, Aniko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3393339/
https://www.ncbi.nlm.nih.gov/pubmed/22843631
http://dx.doi.org/10.1093/jrr/rrs004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3393339/
https://www.ncbi.nlm.nih.gov/pubmed/22843631
http://dx.doi.org/10.1093/jrr/rrs004

Ejemplares similares